Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxidation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Novel copper-catalyzed oxidation method for CDK 4/6 inhibitor intermediates. High yield, low cost, scalable process for pharmaceutical manufacturing supply chains.
Novel one-pot two-step method using Iron(II) phthalocyanine for high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability.
Patent CN111362807B details a green aerobic oxidation route for 3-nitro-2-methylbenzoic acid, offering high purity and reduced waste for pharmaceutical supply chains.
Patent CN111440147B details a convergent route for Imatinib intermediates with high purity and mild conditions, offering reliable supply chain solutions.
Novel stereoselective route for tea geometrid sex pheromone using cheap diol. High yield, >98% ee, scalable for green pest control supply chains.
Patent CN113185433A discloses a green synthesis of Menadione Sodium Bisulfite using benzene and lactone, eliminating chromium waste and reducing manufacturing costs significantly.
Novel chemical synthesis of beta-arbutin via fluoroglucose donor. High purity cosmetic intermediate supplier offering cost-effective, scalable production with minimal waste.
Patent CN106279311B details a novel Gastrodin synthesis using montmorillonite and ceric ammonium nitrate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN115477575B details a transition-metal-free synthesis for diaryl ketones. This method offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103044402B details a low-cost chiral oxidation route for Esomeprazole Sodium, offering high purity and supply chain stability for API manufacturing.
Novel synthesis route for Tamiflu intermediate avoiding toxic selenium. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104402690B reveals copper-catalyzed oxidation for high-purity Peretinoin. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing globally.
Patent CN103319560A details a high-yield UDCA synthesis from CDCA using NBS oxidation and Luche reduction, offering cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Advanced 3-step synthesis of Bambuterol HCl via epoxide intermediate. Eliminates hazardous bromination and Pd/C hydrogenation for superior purity and cost efficiency.
Patent CN117385378B reveals green electrooxidation for aromatic aldehydes. Enhance supply chain reliability and reduce manufacturing costs with scalable synthesis.
Patent CN102603652A reveals a mild three-step synthesis for 5-formylpyrimidine carbocyclic nucleosides, offering a reliable route for antiviral intermediate manufacturing.
Discover the patented electrochemical oxidation method for high-purity p-methylsulfonylbenzoic acid. A reliable pharmaceutical intermediate supplier offering green, scalable production.
Patent CN103408532A details a green oxidation method for PPIs using ion exchange resin and hydrogen peroxide, offering high purity and scalable manufacturing advantages.
Patent CN111848450A discloses a mild route to acyloxyenamines. This method offers high yields and avoids hazardous oxidants for scalable manufacturing.